Mergers & Acquisitions

The grocery retailer will open a store at Vornado Realty Trust’s 770 Broadway, the former home of Kmart.

In his inaugural column, DSN editor in chief and editorial director Nigel F. Maynard discusses what pharmacies will look like as they adapt to a changing market.

Spiriva Handihaler had a market value of $1.5 billion for the 12 months ended May 2021, although actual generic market values are expected to be lower.

Mack Elevation’s Dan Mack shares insights from suppliers and retailers about how both are approaching their business relationships and offers advice for strengthening the supplier-retailer partnership.

As they continue to navigate pandemic headwinds, generics firms look to broaden their portfolios and vertically integrate to keep competitive.

Sun Pharma will have the exclusive right to commercialize Winlevi in the United States and Canada, and Cassiopea will be the exclusive supplier of the product.

The FDS Amplicare business that is being acquired had roughly $29 million of total revenue for the 12 months ended June 30.

Biosimilar ustekinumab will provide a treatment of autoimmune and inflammatory diseases such as plaque psoriasis, Crohn's disease and ulcerative colitis.